Florus C de Jong
7PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 28, 2026
Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.Melinda Lillesand, Marie Austdal, Jakub Mroz
|Jan 03, 2025
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.Florus C de Jong, Vebjørn Kvikstad, Robert F Hoedemaeker
|Sep 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.Joel R Eisner, Florus C de Jong, Yoichiro Shibata
|Aug 02, 2024
Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification.Mitchell Olislagers, Florus C de Jong, Vera C Rutten
|May 24, 2023
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.Florus C de Jong, Teemu D Laajala, Robert F Hoedemaeker
|Sep 23, 2022
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.Sébastien Rinaldetti, Qiong Zhou, Joshua M Abbott
Pageof 2
Frequent Collaborators
2 joint publications
Emiel A M Janssen
2 joint publications
Tahlita C M Zuiverloon
2 joint publications
Joost L Boormans
1 joint publications
Vera C Rutten
1 joint publications
Sébastien Rinaldetti
1 joint publications
Joshua M Abbott
1 joint publications
Hector Esquer
1 joint publications
Teemu D Laajala
1 joint publications
Kimberley R Jordan
1 joint publications
Deric K E van der Schoot
